Multiparametric MRI (mpMRI) is increasingly used as part of the diagnostic evaluation
for prostate cancer (PCa). While mpMRI with targeted biopsy appears to increase the
detection of clinically-significant cancer and reduce overdiagnosis of low-risk cancer,
1
a substantial proportion of Grade Group ≥2 (GG ≥2) lesions are not visible on mpMRI.
2
,3
The clinical significance of mpMRI-invisible lesions remains unclear, and limited
data exist describing the course of mpMRI-negative PCa.To read this article in full you will need to make a payment
Purchase one-time access:
Academic & Personal: 24 hour online accessCorporate R&D Professionals: 24 hour online accessOne-time access price info
- For academic or personal research use, select 'Academic and Personal'
- For corporate R&D use, select 'Corporate R&D Professionals'
Subscribe:
Subscribe to UrologyAlready a print subscriber? Claim online access
Already an online subscriber? Sign in
Register: Create an account
Institutional Access: Sign in to ScienceDirect
References
- Diagnostic accuracy of multi-parametric MRI and TRUS biopsy in prostate cancer(PROMIS): a paired validating confirmatory study.Lancet. 2017; 389: 815-822https://doi.org/10.1016/S0140-6736(16)32401-1
- Biologic significance of magnetic resonance imaging invisibility in localized prostate cancer.JCO Precis Oncol. 2019; : 1-12https://doi.org/10.1200/po.19.00054
- Detection of individual prostate cancer foci via multiparametric magnetic resonance maging.Eur Urol. 2019; 75: 712-720https://doi.org/10.1016/j.eururo.2018.11.031
- Performance characteristics of MR imaging in the evaluation of clinically low-risk prostate cancer: a prospective study.Radiology. 2012; 265: 478-487https://doi.org/10.1148/radiol.12120041
- Multifocality and prostate cancer detection by multiparametric magnetic resonance imaging: Correlation with whole-mount histopathology.Eur Urol. 2015; 67: 569-576https://doi.org/10.1016/j.eururo.2014.08.079
- Impact of gleason subtype on prostate cancer detection using multiparametric magnetic resonance imaging: correlation with final histopathology.J Urol. 2017; 198: 316-321https://doi.org/10.1016/j.juro.2017.01.077
- Optimized b-value selection for the discrimination of prostate cancer grades, including the cribriform pattern, using diffusion weighted imaging.J Med Imaging. 2017; 5: 1https://doi.org/10.1117/1.jmi.5.1.011004
- What Type of prostate cancer is systematically overlooked by multiparametric magnetic resonance imaging? An analysis from the PROMIS cohort.Eur Urol. 2020; 78: 163-170https://doi.org/10.1016/j.eururo.2020.04.029
- Genomic evaluation of multiparametric magnetic resonance imaging-visible and -nonvisible lesions in clinically localised prostate cancer.Eur Urol Oncol. 2019; 2: 1-11https://doi.org/10.1016/j.euo.2018.08.005
- Negative predictive value of multiparametric magnetic resonance imaging in the detection of clinically significant prostate cancer in the prostate imaging reporting and data system era: a systematic review and meta-analysis negative predictive value of mu.Eur Urol. 2020; https://doi.org/10.1016/j.eururo.2020.03.048
- Variability of the positive predictive value of PI-RADS for prostate MRI across 26 centers: experience of the society of abdominal radiology prostate cancer disease-focused panel.Radiology. 2020; 190646https://doi.org/10.1148/radiol.2020190646
Article info
Identification
Copyright
© 2020 Published by Elsevier Inc.
